RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Envisia Therapeutics today announced that it has named Eric Linsley as the Company's Chief Financial Officer. Prior to Envisia, Mr. Linsley was a managing partner at Pappas Ventures in Durham, NC where he was directly responsible for investments that led to several very successful acquisitions and public offerings. He brings with him more than 20 years of experience and a proven track record of finance and life science investment expertise.